Drug Trial Radar · NCT01520987
Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects
Last checked: Nov 19, 2026Latest source record: Jun 20, 2016 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
105
Actual
Start
May 2011
Primary completion
Nov 2012
Study completion Nov 2012
Sponsor
- Lead sponsor
- Bial - Portela C S.A.Industry
- Sponsor type
- Industry
- First posted
- Jan 30, 2012
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To assess the pharmacokinetics of BIA 9-1067 in healthy Japanese subjects
Conditions
- Parkinson Disease
Interventions
BIA 9-1067Drug
5 mg, 25 mg, and 50 mg of BIA 9-1067 (once-daily).
PlaceboDrug
once-daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cmax of BIA 9-1067 - Maximum Observed Plasma Concentration of BIA 9-1067 (Day 1)Time frame: Day 1
- Cmax of BIA 9-1067 - Maximum Observed Plasma Concentration of BIA 9-1067 (Day 10)Time frame: Day 10
- AUC0-t - Area Under the Concentration-time Curve (AUC) From Time Zero to Last Time Point With Concentrations Above the Lower Limit of Quantitation of BIA 9-1067 (Day 1)Time frame: Day 1
- AUC0-t - Area Under the Concentration-time Curve (AUC) From Time Zero to Last Time Point With Concentrations Above the Lower Limit of Quantitation of BIA 9-1067 (Day 10)Time frame: Day 10
- AUC0-∞ - Area Under the Concentration of BIA 9-1067-time Curve (AUC) From Time Zero to Infinity (Day 1)Time frame: Day 1
- AUC0-∞ - Area Under the Concentration of BIA 9-1067-time Curve (AUC) From Time Zero to Infinity (Day 10)Time frame: Day 10
- Tmax of BIA 9-1067 - Time Taken to Reach Maximum Observed Plasma Concentration of BIA 9-1067 (Day 1)Time frame: Day 1
- Tmax of BIA 9-1067 - Time Taken to Reach Maximum Observed Plasma Concentration of BIA 9-1067 (Day 10)Time frame: Day 10
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Covance Clinical Research Unit, Inc.
Honolulu, Hawaii
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.